ISSN Print 2500–1094
ISSN Online 2542–1204
BIOMEDICAL JOURNAL OF PIROGOV UNIVERSITY (MOSCOW, RUSSIA)
Copyright: © 2025 by the authors. Licensee: Pirogov University.
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (CC BY).
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (CC BY).
ORIGINAL RESEARCH
Predictive model for mortality in patients with abdominal sepsis
About authors
1 South Ural State Medical University, Chelyabinsk, Russia
2 City Clinical Hospital No. 8, Chelyabinsk, Russia
3 Chelyabinsk Regional Clinical Hospital, Chelyabinsk, Russia
Correspondence should be addressed: Mikhail V. Osikov
ur.xednay@vokiso.forp
About paper
Author contribution: Osikov MV, Telesheva LF, Konashov AG — study concept and design; Konashov VA, Konashov AG, Gusev AV, Boyko MS — data acquisition and processing; Konashov VA, Konashov AG — manuscript writing; Osikov MV — editing.
Compliance with ethical standards: the study was approved by the Ethics Committee of the South Ural State Medical University (protocol No. 10 dated 02 November 2023).
Received: 2025-01-31
Accepted: 2025-02-14
Published online: 2025-02-23
|
Fig. The metrics used for the model for predicting fatal outcomes in AS
Table 1. Clinical and prognostic scores of patients with beneficial and adverse AS outcomes, Ме (LQ; UQ)
Note: * — significant (p < 0.05) differences from group 1 on appropriate day.
Table 2. Complete blood counts of patients with AS, Ме (LQ; UQ)
Note: * — significant (p < 0.05) differences from group 1 on appropriate day; # — differences from indicators reported on day 1 for appropriate group; $ — differences from indicators reported on day 3 for appropriate group.
Table 3. Biochemistry indicators of patients with AS, Ме (LQ; UQ)
Note: * — significant (p < 0.05) differences from group 1 on appropriate day; # — differences from indicators reported on day 1 for appropriate group; $ — differences from indicators reported on day 3 for appropriate group.
Table 4. Hemostasis indicators of patients with AS, Ме (LQ; UQ)
Note: * — significant (p < 0.05) differences from group 1 on appropriate day; # — differences from indicators reported on day 1 for appropriate group; $ — differences from indicators reported on day 3 for appropriate group.
Table 5. Blood acid-base balance and blood gases in patients with AS, Ме (LQ; UQ)
Note: * — significant (p < 0.05) differences from group 1 on appropriate day; # — differences from indicators reported on day 1 for appropriate group; $ — differences from indicators reported on day 3 for appropriate group.
